15 results
8-K
EX-99.1
YMAB
Y-Mabs Therapeutics Inc
4 Mar 24
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
6:05am
in 2023. She was named to the Women who Lead in Life Sciences and Most Influential Women in Business lists by the San Francisco Business Times in 2019. Dr
8-K
YMAB
Y-Mabs Therapeutics Inc
4 Mar 24
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
6:05am
, San Francisco. Dr. Tagliaferri was honored as an Eminent Woman Leader in Healthcare by Inc Magazine in 2023. She was named to the Women who Lead in Life … Sciences and Most Influential Women in Business lists by the San Francisco Business Times in 2019. Dr. Tagliaferri was also recognized as Woman
8-K
EX-99.1
eqvx8ye7bc2bx6
13 Sep 21
Y-mAbs Announces Priority Review of BLA for DANYELZA® (naxitamab-gqgk) in China
10:06am
8-K
g0t3o5
19 Feb 21
Y-mAbs Announces Proposed Public Offering of Common Stock
6:01am
424B5
c7r5dtl ii
18 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
awl68
17 Feb 21
Prospectus supplement for primary offering
6:02am
10-K
7uq8x1bqg3 s12
22 Mar 19
Annual report
4:02pm
424B4
ebbahf4 u77sencw3x3
21 Sep 18
Prospectus supplement with pricing info
7:33pm
DRS/A
zcl88y06
8 Jun 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next